What's New on the FDA Drugs Site
August 3, 2015
- Fees for Human Drug Compounding Outsourcing Facilities Under Sections 503B and 744K of the FD&C Act Guidance for Industry (PDF - 119KB)
- Baxter Initiates Voluntary Nationwide Recall of One Lot of IV Solution Due to the Potential For Leaking Containers, Particulate Matter and Missing Port Protectors
- FDA Drug Shortages
- Cefazolin Injection (Updated - Currently in Shortage)
- Imipenem and Cilastatin for Injection, USP (Updated - Currently in Shortage)
- Piperacillin and Tazobactam (Zosyn) Injection (Updated - Currently in Shortage)
- Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets
.png)
No hay comentarios:
Publicar un comentario